Novel Therapies in Cancer: Trials and Tribulations.

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

Clinical trials are the backbone for advancing therapeutic options for patients diagnosed with cancer. Yet only 7.1% of patients with cancer participate in clinical trials in the United States. In this article, we review some of the reasons for poor accrual and discuss potential solutions. See related article by van Berge Henegouwen et al., p. 3937.

Keyphrases

clinical trial
papillary thyroid
end stage renal disease
squamous cell
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
lymph node metastasis
squamous cell carcinoma
young adults